色素-话题@MedSci

#色素#

654篇内容 | 6207人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680532, encodeId=3837168053210, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤, objectType=article, longId=139275, objectId=a4201392e56f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4201392e56f, replyNumber=0, likeNumber=0, createdTime=2018-11-11, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4201392e56f, moduleTitle=Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4201392e56f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680572, encodeId=a2eb16805e215, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：基线肿瘤大小是接受Pembrolizumab治疗的黑色素瘤患者的独立预后因素, objectType=article, longId=152303, objectId=fde3152303bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fde3152303bb, replyNumber=0, likeNumber=61, createdTime=2018-11-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fde3152303bb, moduleTitle=CLIN CANCER RES：基线肿瘤大小是接受Pembrolizumab治疗的黑色素瘤患者的独立预后因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fde3152303bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680514, encodeId=c2db1680514d2, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：新的BRAF/MEK联合抑制方案用于BRAF突变型黑色素瘤, objectType=article, longId=134563, objectId=3e681345639b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e681345639b, replyNumber=0, likeNumber=84, createdTime=2018-06-25, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e681345639b, moduleTitle=Lancet Oncol：新的BRAF/MEK联合抑制方案用于BRAF突变型黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e681345639b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680544, encodeId=f75a168054466, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=ANN ONCOL：免疫检查点抑制剂耐药的黑色素瘤中分离出的T细胞依然具有功能, objectType=article, longId=145451, objectId=25d31454512f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25d31454512f, replyNumber=0, likeNumber=72, createdTime=2019-01-11, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25d31454512f, moduleTitle=ANN ONCOL：免疫检查点抑制剂耐药的黑色素瘤中分离出的T细胞依然具有功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25d31454512f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680507, encodeId=ff7d168050ecd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=肩关节色素性绒毛结节性滑膜炎合并肩袖巨大撕裂1例, objectType=article, longId=133066, objectId=aa3113306627, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa3113306627, replyNumber=0, likeNumber=72, createdTime=2018-05-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa3113306627, moduleTitle=肩关节色素性绒毛结节性滑膜炎合并肩袖巨大撕裂1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa3113306627)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680555, encodeId=09be16805553d, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Biochem Biophys Res Commun：抑制NKILA可以促进NFκB活化，保护视网膜色素上皮细胞免于缺氧损害, objectType=article, longId=148555, objectId=b13e14855538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b13e14855538, replyNumber=0, likeNumber=79, createdTime=2018-09-11, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b13e14855538, moduleTitle=Biochem Biophys Res Commun：抑制NKILA可以促进NFκB活化，保护视网膜色素上皮细胞免于缺氧损害, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b13e14855538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680513, encodeId=f5b0168051355, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Vis Exp：小鼠视网膜色素上皮细胞的原代细胞培养方案, objectType=article, longId=134443, objectId=40e7134443c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40e7134443c4, replyNumber=0, likeNumber=58, createdTime=2019-02-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40e7134443c4, moduleTitle=J Vis Exp：小鼠视网膜色素上皮细胞的原代细胞培养方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40e7134443c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680551, encodeId=971b16805515e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=免疫治疗用于黑色素瘤新辅助和辅助治疗的新近进展, objectType=article, longId=147734, objectId=a8fc14e73451, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8fc14e73451, replyNumber=0, likeNumber=74, createdTime=2019-08-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8fc14e73451, moduleTitle=免疫治疗用于黑色素瘤新辅助和辅助治疗的新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8fc14e73451)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680494, encodeId=4ddb1680494ef, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=原发部位不明的颅内黑色素瘤1例, objectType=article, longId=127141, objectId=baa112e141bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=baa112e141bf, replyNumber=0, likeNumber=63, createdTime=2018-11-24, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=baa112e141bf, moduleTitle=原发部位不明的颅内黑色素瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=baa112e141bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680578, encodeId=c06516805e844, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Methods Mol Biol：人类动物模型视网膜色素上皮-脉络膜外植体培养物综述, objectType=article, longId=153925, objectId=713d15392548, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713d15392548, replyNumber=0, likeNumber=66, createdTime=2019-10-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713d15392548, moduleTitle=Methods Mol Biol：人类动物模型视网膜色素上皮-脉络膜外植体培养物综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=713d15392548)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680521, encodeId=eba1168052110, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：Pembrolizumab联合聚乙二醇干扰素或Ipilimumab治疗晚期黑色素瘤或肾细胞癌, objectType=article, longId=136477, objectId=7a5f1364e7eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a5f1364e7eb, replyNumber=0, likeNumber=70, createdTime=2018-07-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a5f1364e7eb, moduleTitle=CLIN CANCER RES：Pembrolizumab联合聚乙二醇干扰素或Ipilimumab治疗晚期黑色素瘤或肾细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a5f1364e7eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680508, encodeId=5c6816805089c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Brit J Cancer：NF1突变与结膜黑色素瘤！, objectType=article, longId=133144, objectId=d1fb1331447c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1fb1331447c, replyNumber=0, likeNumber=68, createdTime=2018-11-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1fb1331447c, moduleTitle=Brit J Cancer：NF1突变与结膜黑色素瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1fb1331447c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680524, encodeId=482e168052481, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=诺华BRAF抑制剂与MEK抑制剂获FDA批准联合靶向治疗黑色素瘤, objectType=article, longId=137007, objectId=d64a13e007c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d64a13e007c3, replyNumber=0, likeNumber=67, createdTime=2018-09-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d64a13e007c3, moduleTitle=诺华BRAF抑制剂与MEK抑制剂获FDA批准联合靶向治疗黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d64a13e007c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680582, encodeId=8b04168058270, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Ann Surg：隆胸需谨慎！**癌症研究中心科学家分析近十万人数据显示，硅胶植入或与黑色素瘤风险增加4倍，自免病风险增加8倍等有关, objectType=article, longId=155096, objectId=a6a415509662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6a415509662, replyNumber=0, likeNumber=76, createdTime=2019-03-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6a415509662, moduleTitle=Ann Surg：隆胸需谨慎！**癌症研究中心科学家分析近十万人数据显示，硅胶植入或与黑色素瘤风险增加4倍，自免病风险增加8倍等有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6a415509662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680489, encodeId=dde716804891c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cell：人类皮肤色素沉着的遗传学特征远比想象中的更加复杂, objectType=article, longId=125790, objectId=2145125e9018, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2145125e9018, replyNumber=0, likeNumber=71, createdTime=2018-05-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2145125e9018, moduleTitle=Cell：人类皮肤色素沉着的遗传学特征远比想象中的更加复杂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2145125e9018)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680559, encodeId=9cd816805594c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NICE支持Tafinlar与Mekinist的组合治疗晚期黑色素瘤, objectType=article, longId=149047, objectId=197214904e64, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=197214904e64, replyNumber=0, likeNumber=69, createdTime=2019-07-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=197214904e64, moduleTitle=NICE支持Tafinlar与Mekinist的组合治疗晚期黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=197214904e64)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680516, encodeId=52f3168051674, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：Keytruda辅助治疗可显著提高III期黑色素瘤患者生存率, objectType=article, longId=135501, objectId=edf51355017d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edf51355017d, replyNumber=0, likeNumber=65, createdTime=2019-03-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edf51355017d, moduleTitle=NEJM：Keytruda辅助治疗可显著提高III期黑色素瘤患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edf51355017d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680548, encodeId=fb54168054841, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：纳武单抗联合易普利姆玛用于黑色素瘤脑转移, objectType=article, longId=147285, objectId=fc9314e285e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc9314e285e1, replyNumber=0, likeNumber=88, createdTime=2019-07-18, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc9314e285e1, moduleTitle=NEJM：纳武单抗联合易普利姆玛用于黑色素瘤脑转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc9314e285e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680568, encodeId=19da16805682e, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=【盘点】黑色素瘤近期重要原始研究汇总, objectType=article, longId=151511, objectId=ff8a151511ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff8a151511ee, replyNumber=0, likeNumber=50, createdTime=2019-06-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff8a151511ee, moduleTitle=【盘点】黑色素瘤近期重要原始研究汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff8a151511ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680498, encodeId=fcfd168049823, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NCCN临床实践指南：黑色素瘤（2018.V2）, objectType=article, longId=128545, objectId=480d1285451c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=480d1285451c, replyNumber=0, likeNumber=14, createdTime=2018-12-07, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=480d1285451c, moduleTitle=NCCN临床实践指南：黑色素瘤（2018.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=480d1285451c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Oncotarget：司美替尼药物组合治疗葡萄膜黑色素瘤

2018-11-11

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：基线肿瘤大小是接受Pembrolizumab治疗的黑色素瘤患者的独立预后因素

2018-11-26

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：新的BRAF/MEK联合抑制方案用于BRAF突变型黑色素瘤

2018-06-25

sunylz (审核中...)

前往app查看评论内容

#色素#

ANN ONCOL：免疫检查点抑制剂耐药的黑色素瘤中分离出的T细胞依然具有功能

2019-01-11

sunylz (审核中...)

前往app查看评论内容

#色素#

肩关节色素性绒毛结节性滑膜炎合并肩袖巨大撕裂1例

2018-05-16

sunylz (审核中...)

前往app查看评论内容

#色素#

Biochem Biophys Res Commun：抑制NKILA可以促进NFκB活化，保护视网膜色素上皮细胞免于缺氧损害

2018-09-11

sunylz (审核中...)

前往app查看评论内容

#色素#

J Vis Exp：小鼠视网膜色素上皮细胞的原代细胞培养方案

2019-02-04

sunylz (审核中...)

前往app查看评论内容

#色素#

免疫治疗用于黑色素瘤新辅助和辅助治疗的新近进展

2019-08-02

sunylz (审核中...)

前往app查看评论内容

#色素#

原发部位不明的颅内黑色素瘤1例

2018-11-24

sunylz (审核中...)

前往app查看评论内容

#色素#

Methods Mol Biol：人类动物模型视网膜色素上皮-脉络膜外植体培养物综述

2019-10-31

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：Pembrolizumab联合聚乙二醇干扰素或Ipilimumab治疗晚期黑色素瘤或肾细胞癌

2018-07-26

sunylz (审核中...)

前往app查看评论内容

#色素#

Brit J Cancer：NF1突变与结膜黑色素瘤！

2018-11-04

sunylz (审核中...)

前往app查看评论内容

#色素#

诺华BRAF抑制剂与MEK抑制剂获FDA批准联合靶向治疗黑色素瘤

2018-09-01

sunylz (审核中...)

前往app查看评论内容

#色素#

Ann Surg：隆胸需谨慎！**癌症研究中心科学家分析近十万人数据显示，硅胶植入或与黑色素瘤风险增加4倍，自免病风险增加8倍等有关

2019-03-04

sunylz (审核中...)

前往app查看评论内容

#色素#

Cell：人类皮肤色素沉着的遗传学特征远比想象中的更加复杂

2018-05-02

sunylz (审核中...)

前往app查看评论内容

#色素#

NICE支持Tafinlar与Mekinist的组合治疗晚期黑色素瘤

2019-07-21

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：Keytruda辅助治疗可显著提高III期黑色素瘤患者生存率

2019-03-03

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：纳武单抗联合易普利姆玛用于黑色素瘤脑转移

2019-07-18

sunylz (审核中...)

前往app查看评论内容

#色素#

【盘点】黑色素瘤近期重要原始研究汇总

2019-06-01

sunylz (审核中...)

前往app查看评论内容

#色素#

NCCN临床实践指南：黑色素瘤（2018.V2）

2018-12-07

科室
- - 订阅+
  - 更多科室
工具
服务